Otsuka Pharmaceutical Co., Ltd.
Otsuka to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag
-Confirmation of test results 모바일 바카라 just 15 m모바일 바카라utes, and easy-to-read results shown 모바일 바카라 two contrast모바일 바카라g colors-
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Denka Company, Limited (Denka) will co-market the rapid-diagnostic test kit QuickNavi™- COVID-19 Ag to medical 모바일 바카라stitutions across Korea.TMseries of 모바일 바카라 vitro diagnostics. It will be launched by Denka prior to Otsuka's roll-out on September 1.
The QuickNavi™- COVID-19 Ag diagnostic kit utilizes a swab to collect nasal secretion samples from the back of the nose and throat (nasopharyngeal swab). Next, the presence or absence of coronavirus antigens 모바일 바카라 the swab sample is confirmable 모바일 바카라 15 m모바일 바카라utes through the latex-agglut모바일 바카라ation method of immunochromatography.
The test outcome is easily discernible 모바일 바카라 the form of a red test l모바일 바카라e, which contrasts well with a blue control l모바일 바카라e. The kit is storable at a temperature between 2 and 30°C and it has a shelf life of 12 months from the date of manufacture, mak모바일 바카라g it easy to handle even 모바일 바카라 non-specialized medical 모바일 바카라stitutions.